Pfizer top pharma company on 2006 Fortune 500 list

Share this article:
Pfizer was the top-ranked pharmaceutical company on this year’s Fortune 500 list, coming in at No. 31 with $53 million in revenues. Johnson and Johnson trailed behind Pfizer at No. 32 with nearly $51 million in revenues, followed by Abbott Laboratories at No. 93 with $22 million in revenues, Merck at No. 95 with $22 million in revenues and Bristol-Myers Squibb at No. 110 with $20 million in revenues. Rounding out the top 10 pharma companies on the 2006 list were Eli Lilly at No. 148, Amgen at No. 181, Schering-Plough at No. 250 and Forest Laboratories at No. 588. The Fortune 500 list is an annual ranking of America’s largest corporations by revenue. The full Fortune 500 list will be published in the April 17 issue of the magazine.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Sales

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.